0008-4510 : Mylotarg 5 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution
| NDC: | 0008-4510 |
| Labeler: | Wyeth Pharmaceuticals Inc., a Subsidiary of Pfizer Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Mylotarg |
| Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Solution |
| Application #: | BLA761060 |
| Rev. Date: |
NDC Package Codes:
- 0008-4510-01: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (0008‑4510‑01) > 5 ML IN 1 VIAL, SINGLE‑DOSE
Active Ingredients:
- Gemtuzumab Ozogamicin
Dosage Strength:
- 5 mg/5mL
Pharmaceutical Classes:
- CD33-directed Immunoconjugate [EPC]
- CD33-directed Antibody Interactions [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0008-4188Next: 0008-4990 >
Related Discussions:
Mylotarg and Increased Mortality Risk
My mom died two weeks after receiving two doses of mylotarg in May of 2010. Since her death certificate says her death w... 2 replies
My mom died two weeks after receiving two doses of mylotarg in May of 2010. Since her death certificate says her death w... 2 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.